These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 27789573)

  • 1. A
    Ishii A; Kang JQ; Schornak CC; Hernandez CC; Shen W; Watkins JC; Macdonald RL; Hirose S
    J Med Genet; 2017 Mar; 54(3):202-211. PubMed ID: 27789573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The de novo missense mutation F224S in GABRB2, identified in epileptic encephalopathy and developmental delay, impairs GABA
    Li PP; Zhou YY; Gao L; Lv JN; Xu SS; Zhao YW; Xu D; Huang R; Zhang X; Li P; Fu X; He Z
    Neuroscience; 2024 Aug; 553():172-184. PubMed ID: 38964454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic spectrum of patients with GABRB2 variants: from mild febrile seizures to severe epileptic encephalopathy.
    Yang Y; Xiangwei W; Zhang X; Xiao J; Chen J; Yang X; Jia T; Yang Z; Jiang Y; Zhang Y
    Dev Med Child Neurol; 2020 Oct; 62(10):1213-1220. PubMed ID: 32686847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three epilepsy-associated GABRG2 missense mutations at the γ+/β- interface disrupt GABAA receptor assembly and trafficking by similar mechanisms but to different extents.
    Huang X; Hernandez CC; Hu N; Macdonald RL
    Neurobiol Dis; 2014 Aug; 68():167-79. PubMed ID: 24798517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo GABRA1 mutations in Ohtahara and West syndromes.
    Kodera H; Ohba C; Kato M; Maeda T; Araki K; Tajima D; Matsuo M; Hino-Fukuyo N; Kohashi K; Ishiyama A; Takeshita S; Motoi H; Kitamura T; Kikuchi A; Tsurusaki Y; Nakashima M; Miyake N; Sasaki M; Kure S; Haginoya K; Saitsu H; Matsumoto N
    Epilepsia; 2016 Apr; 57(4):566-73. PubMed ID: 26918889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo GABRG2 mutations associated with epileptic encephalopathies.
    Shen D; Hernandez CC; Shen W; Hu N; Poduri A; Shiedley B; Rotenberg A; Datta AN; Leiz S; Patzer S; Boor R; Ramsey K; Goldberg E; Helbig I; Ortiz-Gonzalez XR; Lemke JR; Marsh ED; Macdonald RL
    Brain; 2017 Jan; 140(1):49-67. PubMed ID: 27864268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpressing wild-type γ2 subunits rescued the seizure phenotype in Gabrg2
    Huang X; Zhou C; Tian M; Kang JQ; Shen W; Verdier K; Pimenta A; MacDonald RL
    Epilepsia; 2017 Aug; 58(8):1451-1461. PubMed ID: 28586508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of intractable life-threatening seizures with perampanel in the first case of early myoclonic encephalopathy with a novel de novo SCN1A mutation.
    Ishikawa N; Tateishi Y; Tani H; Kobayashi Y; Itai T; Miyatake S; Kato M; Matsumoto N; Kobayashi M
    Seizure; 2019 Oct; 71():20-23. PubMed ID: 31176277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GABRB3 mutations: a new and emerging cause of early infantile epileptic encephalopathy.
    Papandreou A; McTague A; Trump N; Ambegaonkar G; Ngoh A; Meyer E; Scott RH; Kurian MA
    Dev Med Child Neurol; 2016 Apr; 58(4):416-20. PubMed ID: 26645412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A patient with early myoclonic encephalopathy (EME) with a de novo KCNQ2 mutation.
    Kojima K; Shirai K; Kobayashi M; Miyauchi A; Saitsu H; Matsumoto N; Osaka H; Yamagata T
    Brain Dev; 2018 Jan; 40(1):69-73. PubMed ID: 28687180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered Channel Conductance States and Gating of GABA
    Hernandez CC; Kong W; Hu N; Zhang Y; Shen W; Jackson L; Liu X; Jiang Y; Macdonald RL
    eNeuro; 2017; 4(1):. PubMed ID: 28197552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant GABA(A) receptor subunits in genetic (idiopathic) epilepsy.
    Hirose S
    Prog Brain Res; 2014; 213():55-85. PubMed ID: 25194483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical features of epilepsies associated with GABRB2 variants].
    Yang Y; Zhang YH; Chen JY; Zhang J; Yang XL; Chen Y; Yang ZX; Wu XR
    Zhonghua Er Ke Za Zhi; 2019 Jul; 57(7):532-537. PubMed ID: 31269553
    [No Abstract]   [Full Text] [Related]  

  • 14. A novel mutation in STXBP1 gene in a child with epileptic encephalopathy and an atypical electroclinical pattern.
    Romaniello R; Zucca C; Tenderini E; Arrigoni F; Ragona F; Zorzi G; Bassi MT; Borgatti R
    J Child Neurol; 2014 Feb; 29(2):249-53. PubMed ID: 24170257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of nonsense mutation in GABRG2 with abnormal trafficking of GABAA receptors in severe epilepsy.
    Ishii A; Kanaumi T; Sohda M; Misumi Y; Zhang B; Kakinuma N; Haga Y; Watanabe K; Takeda S; Okada M; Ueno S; Kaneko S; Takashima S; Hirose S
    Epilepsy Res; 2014 Mar; 108(3):420-32. PubMed ID: 24480790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synaptic clustering differences due to different GABRB3 mutations cause variable epilepsy syndromes.
    Shi YW; Zhang Q; Cai K; Poliquin S; Shen W; Winters N; Yi YH; Wang J; Hu N; Macdonald RL; Liao WP; Kang JQ
    Brain; 2019 Oct; 142(10):3028-3044. PubMed ID: 31435640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-Phenylbutyrate promoted wild-type γ-aminobutyric acid type A receptor trafficking, reduced endoplasmic reticulum stress, and mitigated seizures in Gabrg2
    Shen W; Flamm C; Delahanty AJ; Casteel E; Biven M; DeLeeuw MB; Poliquin S; Nwosu G; Randhave K; Kang JQ
    Epilepsia; 2024 Jan; 65(1):204-217. PubMed ID: 37746768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Pathogenic Basis for GABRG2 Mutations Associated With a Spectrum of Epilepsy Syndromes, From Generalized Absence Epilepsy to Dravet Syndrome.
    Kang JQ; Macdonald RL
    JAMA Neurol; 2016 Aug; 73(8):1009-16. PubMed ID: 27367160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal epileptic encephalopathy caused by de novo GNAO1 mutation misdiagnosed as atypical Rett syndrome: Cautions in interpretation of genomic test results.
    Gerald B; Ramsey K; Belnap N; Szelinger S; Siniard AL; Balak C; Russell M; Richholt R; De Both M; Claasen AM; Schrauwen I; Huentelman MJ; Craig DW; Rangasamy S; Narayanan V
    Semin Pediatr Neurol; 2018 Jul; 26():28-32. PubMed ID: 29961512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo variants in GABRA2 and GABRA5 alter receptor function and contribute to early-onset epilepsy.
    Butler KM; Moody OA; Schuler E; Coryell J; Alexander JJ; Jenkins A; Escayg A
    Brain; 2018 Aug; 141(8):2392-2405. PubMed ID: 29961870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.